Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Cannabidiol modulates expression of type I IFN response genes and HIV infection in macrophages

Frontiers in Immunology(2022)10.3389/fimmu.2022.926696Source: DataRank Database

Cannabidiol modulates expression of type I IFN response genes and HIV infection in macrophages is a research paper published in Frontiers in Immunology (2022). On theSindex it has a DataRank of 0. It has been cited 26 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access26 citations

Download PDF

Cite:

Linked data & code

geo doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (13 grants)Impact (FWCI 1.52)OA: goldTopics (114)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Wenli Mu ORCID,Gajendra W. Suryawanshi ORCID,Hwee L. Ng,Li Wang ORCID,Wally Wennerberg

Live enrichment

PubMed:36248834 PMC:PMC9560767 OpenAlex:https://openalex.org/W4297997782

NIAID NIH HHS

Grant: R21 AI140866

NIAID NIH HHS

Grant: U19 AI149504

NIAID NIH HHS

Grant: P30 AI152501

NCI NIH HHS

Grant: R01 CA239261

NIDA NIH HHS

Grant: R01 DA052841

National Institutes of Health

Grant: 5R01DA052841-04

Define the effects and mechanism of THC and CBD on IFN-I mediated inflammation and immune dysfunction during HIV infection

National Institutes of Health

Grant: 5R21AI140866-02

Targeting Autophagy to Restore Anti-HIV T Cell Response

National Institutes of Health

Grant: 5U19AI149504-03

(Attack)2: Genetic engineering of cellular and humoral immunity to cure HIV

National Institutes of Health

Grant: 1R01CA239261-01

Role of persistent type I IFN signaling in immune suppression and tumorigenesis during chronic HIV infection

National Institutes of Health

Grant: 5P30AI028697-26

Biostatistics Core

National Institute of Allergy and Infectious Diseases

National Institutes of Health

National Institute on Drug Abuse

FWCI

1.52

Citation Percentile

0.8%

Influential Citations

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.3389/fimmu.2022.926696

GOLDhttps://doi.org/10.3389/fimmu.2022.926696

publisherhttps://doi.org/10.3389/fimmu.2022.926696

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2022.926696/full

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36248834

Fields of Study

HIV Research and TreatmentImmune Cell Function and InteractionMosquito-borne diseases and controlMedicineBiology0301 basic medicine0303 health sciences03 medical and health sciencesAnti-Inflammatory AgentsCannabidiolHIV InfectionsHumansInterferon Type IMacrophagesNucleotidyltransferasesRNASequestosome-1 Protein

MeSH Terms

Sequestosome-1 ProteinAnti-Inflammatory AgentsCannabidiolHumansInterferon Type IMacrophagesNucleotidyltransferasesRNAHIV Infections

Keywords

CannabidiolAutophagyInterferonBiologyDownregulation and upregulationTHP1 cell lineImmune systemTranscriptomeCell cultureCell biologyImmunologyGene expressionMedicineCannabisApoptosisGeneGeneticsMacrophageType I interferonsIsg (Interferon Stimulated Genes)Hiv - Human Immunodeficiency VirusCbd - CannabidiolTherapeutic Cannabinoid ResearchCannabidiol Research (rcdc)Nucleotidyltransferases (mesh)Anti-Inflammatory AgentsInterferon Type I (mesh)HIV InfectionsSequestosome-1 Protein (mesh)3105 Genetics (for-2020)Anti-Inflammatory Agents (mesh)Substance MisuseClinical Research (rcdc)Sequestosome-1 Protein2.1 Biological and endogenous factors32 Biomedical and Clinical Sciences (for-2020)3101 Biochemistry and cell biology (for-2020)3214 Pharmacology and Pharmaceutical Sciences (for-2020)Humans (mesh)Substance Misuse (rcdc)3 Good Health and Well Being (sdg)human immunodeficiency virusPharmacology and Pharmaceutical SciencesNucleotidyltransferasesInfection (hrcs-hc)Infectious DiseasesCannabidiol (mesh)Medical Microbiology5.1 PharmaceuticalsInterferon Type IHIV/AIDSRNA (mesh)CBDInfection570Cannabidiol Research1.1 Normal biological development and functioning610Therapeutic Cannabinoid Research (rcdc)1107 Immunology (for)HIV Infections (mesh)ISGClinical Research5.1 Pharmaceuticals (hrcs-rac)Humans3207 Medical Microbiology (for-2020)3204 Immunology (for-2020)1.1 Normal biological development and functioning (hrcs-rac)HIV/AIDS (rcdc)Cannabinoid Research (rcdc)Biomedical and Clinical SciencesCannabinoid ResearchGenetics (rcdc)Inflammatory and immune systemMacrophages1108 Medical Microbiology (for)HIV2.1 Biological and endogenous factors (hrcs-rac)RC581-607Inflammatory and immune system (hrcs-hc)Good Health and Well BeingInfectious Diseases (rcdc)Biochemistry and cell biologyMacrophages (mesh)Sexually Transmitted InfectionsRNAImmunologic diseases. AllergySexually Transmitted Infections (rcdc)

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being